Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 6
2004 3
2005 2
2006 3
2007 4
2008 6
2009 10
2010 10
2011 17
2012 22
2013 24
2014 17
2015 13
2016 6
2017 7
2018 12
2019 13
2020 14
2021 16
2022 11
2023 21
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

205 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of the selective TYK2 inhibitor, deucravacitinib, in Japanese patients with moderate to severe plaque psoriasis: Subgroup analysis of a randomized, double-blind, placebo-controlled, global phase 3 trial.
Imafuku S, Tada Y, Hippeli L, Banerjee S, Morita A, Ohtsuki M. Imafuku S, et al. Among authors: tada y. J Dermatol. 2023 May;50(5):588-595. doi: 10.1111/1346-8138.16740. Epub 2023 Mar 7. J Dermatol. 2023. PMID: 36882942 Clinical Trial.
Crosstalk: keratinocytes and immune cells in psoriasis.
Kamata M, Tada Y. Kamata M, et al. Among authors: tada y. Front Immunol. 2023 Nov 9;14:1286344. doi: 10.3389/fimmu.2023.1286344. eCollection 2023. Front Immunol. 2023. PMID: 38022549 Free PMC article. Review.
Immunoresponses in dermatomycoses.
Hau CS, Tada Y, Kanda N, Watanabe S. Hau CS, et al. Among authors: tada y. J Dermatol. 2015 Mar;42(3):236-44. doi: 10.1111/1346-8138.12718. J Dermatol. 2015. PMID: 25736316 Review.
Safety of biologics in psoriasis.
Kamata M, Tada Y. Kamata M, et al. Among authors: tada y. J Dermatol. 2018 Mar;45(3):279-286. doi: 10.1111/1346-8138.14096. Epub 2017 Dec 10. J Dermatol. 2018. PMID: 29226369 Review.
Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study.
Terui T, Okubo Y, Kobayashi S, Sano S, Morita A, Imafuku S, Tada Y, Abe M, Yaguchi M, Uehara N, Handa T, Tanaka M, Zhang W, Paris M, Murakami M. Terui T, et al. Among authors: tada y. Am J Clin Dermatol. 2023 Sep;24(5):837-847. doi: 10.1007/s40257-023-00788-2. Epub 2023 May 26. Am J Clin Dermatol. 2023. PMID: 37233897 Free PMC article. Clinical Trial.
205 results